Analyst consensus rating
Core Laboratories Analyst Rating: Buy
CLB is rated Buy by 3 analysts with a $15.17 target. As of 2026-08-19.
Direct answer
Core Laboratories's consensus rating is Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $15.17.
Forecast evidence checked August 19, 2026.
Get free Core Laboratories email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $12.65
- Average price target
- $15.17
- High price target
- $21.00
- Low price target
- $11.00
- Low target gap
- -13%
- Target upside
- +19.9%
- High target gap
- +66%
- Target range width
- 79.1%
- Consensus rating
- Buy
- Analysts
- 3
- Evidence date
- August 19, 2026
- Valid through
- August 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Core Laboratories?
Core Laboratories has a verified Buy consensus. The same dataset has an average price target of $15.17.
How far are Core Laboratories's low and high targets from the recorded price?
The low target implies -13%, while the high target implies +66%.
How many analysts are included in Core Laboratories's consensus?
The verified consensus includes 3 analysts.
How is Core Laboratories's target upside or downside calculated?
The average target of $15.17 is divided by the recorded price of $12.65, then one is subtracted to produce +19.9%. This does not guarantee a future return.
When was Core Laboratories's analyst forecast verified?
The data was verified on 2026-08-19. The dataset is valid through 2026-08-26.